Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters

Status unconfirmed · Not applicable

Conditions studied: Down Syndrome, Chromosome Abnormalities

In brief

Too much or too little genetic information (chromosome material) can cause abnormal development of the fetus or death. Each year approximately 2.5 million pregnant women are screened for Down Syndrome using invasive screening methods (amniocentesis or chorionic villus sampling). This 11 center study of 38,000 women will compare the accuracy of the several non-invasive tests in the first and second trimesters of pregnancy versus amniocentesis or diagnosis at birth to diagnose aneuploidy or Down Syndrome.

Key facts

Study ID
NCT00006445
Run by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
People needed
38000
Last updated by the study team
2007-02-22

Who can join

Age: 16 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.